BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16211448)

  • 1. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study.
    Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS
    Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.
    Anninga JK; van de Vijver MJ; Cleton-Jansen AM; Kristel PM; Taminiau AH; Nooij M; Egeler RM; Hogendoorn PC
    Eur J Cancer; 2004 May; 40(7):963-70. PubMed ID: 15093570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis.
    Tsiambas E; Karameris A; Dervenis C; Lazaris AC; Giannakou N; Gerontopoulos K; Patsouris E
    JOP; 2006 May; 7(3):283-94. PubMed ID: 16685109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique.
    Langner C; Gross C; Rehak P; Ratschek M; Rüschoff J; Zigeuner R
    Urology; 2005 Jan; 65(1):176-80. PubMed ID: 15667899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
    Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
    Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.
    Kammori M; Kurabayashi R; Kashio M; Sakamoto A; Yoshimoto M; Amano S; Kaminishi M; Yamada T; Takubo K
    Oncol Rep; 2008 Mar; 19(3):651-6. PubMed ID: 18288397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
    Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
    Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L
    Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
    Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
    Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated assessment of potential value of erbB-2 amplification or expression status as novel therapy target in Chinese children and adolescents with osteosarcoma.
    Shang J; Bi ZG; Ji HF; Wang WB
    Chin Med J (Engl); 2009 Jul; 122(13):1521-4. PubMed ID: 19719941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.
    Kanta SY; Yamane T; Dobashi Y; Mitsui F; Kono K; Ooi A
    Hum Pathol; 2006 Oct; 37(10):1333-43. PubMed ID: 16949920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of HER2 overexpression in metastatic malignant melanoma.
    Inman JL; Kute T; White W; Pettenati M; Levine EA
    J Surg Oncol; 2003 Oct; 84(2):82-8. PubMed ID: 14502781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.
    Cornolti G; Ungari M; Morassi ML; Facchetti F; Rossi E; Lombardi D; Nicolai P
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1031-6. PubMed ID: 17938328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma.
    Lee WI; Bacchni P; Bertoni F; Maeng YH; Park YK
    Oncol Rep; 2004 Jul; 12(1):125-8. PubMed ID: 15201972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of human epidermal growth factor receptor 2 protein and gene in fine needle aspiration cytology specimens and tissue sections from invasive breast cancer: can cytology specimens take the place of tissue sections?
    Sumiyoshi K; Shibayama Y; Akashi S; Nohara T; Iwamoto M; Kobayashi T; Nishimura H; Yoshinaka R; Harada T; Tanigawa N
    Oncol Rep; 2006 Apr; 15(4):803-8. PubMed ID: 16525662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.
    Minner S; Jessen B; Stiedenroth L; Burandt E; Köllermann J; Mirlacher M; Erbersdobler A; Eichelberg C; Fisch M; Brümmendorf TH; Bokemeyer C; Simon R; Steuber T; Graefen M; Huland H; Sauter G; Schlomm T
    Clin Cancer Res; 2010 Mar; 16(5):1553-60. PubMed ID: 20179235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival.
    Murphy AJ; Hughes CA; Barrett C; Magee H; Loftus B; O'Leary JJ; Sheils O
    Cancer Res; 2007 Mar; 67(6):2893-8. PubMed ID: 17363613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of HER2 by chromogenic in situ hybridization and immunohistochemistry in lymph node-negative breast carcinoma: Prognostic relevance.
    Peiró G; Aranda FI; Adrover E; Niveiro M; Alenda C; Payá A; Seguí J
    Hum Pathol; 2007 Jan; 38(1):26-34. PubMed ID: 17056098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2/neu (c-erbB-2) gene amplification and protein expression are rare in uterine cervical neoplasia: a tissue microarray study of 814 archival specimens.
    Lesnikova I; Lidang M; Hamilton-Dutoit S; Koch J
    APMIS; 2009 Oct; 117(10):737-45. PubMed ID: 19775342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer.
    Todorović-Raković N; Jovanović D; Nesković-Konstantinović Z; Nikolić-Vukosavljević D
    Exp Mol Pathol; 2007 Jun; 82(3):262-8. PubMed ID: 17335803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.